Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial
- MAGNI, LAURA ROSA
- Carcione, Antonino
- Ferrari, Clarissa
- Semerari, Antonio
- Riccardi, Ilaria
- Nicolo', Giuseppe
- Lanfredi, Mariangela
- Pedrini, Laura
- Cotelli, Maria
- Bocchio, Luisella
- Pievani, Michela
- Gasparotti, Roberto
- Rossi, Roberta
- Rossi R
- Magni LR
- Lanfredi M
- Pedrini L
- Carcione A
- Semerari A
- Riccardi I
- Nicolo' G
- Almici M
- Beneduce R
- Borsci G
- Caprioli C
- Nodari M
- Vita A
- Barlati S
- Laffranchini L
- Rillosi L
- Rossi G
- Bocchio L
- Cattaneo A
- Cattane N
- Tura GB
- Bignotti S
- Speziali M
- Cotelli M
- Rosini S
- Gasparotti R
- Ambrosi C
- Mascaro L
- Corbo D
- Pievani M
- Quattrini G
- Bilotta E
- Colle L
- Conti L
- Fiore D
- Micheloni A
- Procacci M
- Silvestre V.
Publication date
January 2019
DOI Publisher
Springer Science and Business Media LLCAbstract
Borderline Personality Disorder (BPD) is a complex and debilitating disorder, characterized by deficits in metacognition and emotion dysregulation. The "gold standard" treatment for this disorder is psychotherapy with pharmacotherapy as an adjunctive treatment to target state symptoms. The present randomized clinical trial aims to assess the clinical and neurobiological changes following Metacognitive Interpersonal Therapy (MIT) compared with Structured Clinical Management (SCM) derived from specific recommendations in APA (American Psychiatric Association) guidelines for BPD
Add to ORKG